Schedule Update - effective 1 Apr 2007 (text extract)

This is the text extract for Schedule Update - effective 1 Apr 2007, browse documents here.

New Zealand Pharmaceutical Schedule

Effective 1 April 2007

Cumulative for January, February, March and April 2007 Section H for April 2007

Contents

Two new medicines funded for people with HIV infection ............................ 4 Pioglitazone – widened access ...................................................................... 4 New brand of sumatriptan tablets ................................................................ 4 Paroxetine hydrochloride 20 mg tablets – brand change .............................. 4 Close control and delist date: Calcium Carbonate ......................................... 5 Looking Forward ........................................................................................... 6 Tender News .................................................................................................. 6 Sole Subsidised Supply products cumulative to April 2007 ........................... 7 New Listings ................................................................................................ 16 Changes to Restrictions ............................................................................... 21 Changes to Subsidy and Manufacturer’s Price............................................. 27 Changes to General Rules............................................................................ 32 Changes to Brand Name ............................................................................. 32 Changes to Sole Subsidised Supply ............................................................. 33 Changes to PSO........................................................................................... 33 Delisted Items ............................................................................................. 34 Items to be Delisted .................................................................................... 38 Section H changes to Part II ........................................................................ 42 Index ........................................................................................................... 43

Summary of PharmaC decisions

effeCtive 1 aPriL 2007 New listings (pages 16-20) • Hyoscine N-butylbromide (Gastrosoothe) tab 10 mg • Glucose blood diagnostic test meter (Accu-Chek Performa) meter – subsidised for patients initiated on insulin or sulphonylurea therapy after 1 March 2005. Only one meter per patient. No further prescriptions will be subsidised • Glucose dehydrogenase (Accu-Chek Performa) blood/glucose test strip, 50 test OP – maximum per prescription criteria • Lisinopril (Arrow-Lisinopril) tab 5 mg, 10 mg and 20 mg • Emtricitabine (Emtriva) cap 200 mg – Special Authority – Hospital pharmacy [HP1] • Tenofovir disoproxil fumarate (Viread) tab 300 mg – Special Authority – Hospital pharmacy [HP1] • Morphine sulphate (Baxter) suppos 10 mg – only on a controlled drug form – no patient co-payment payable – listed under Section 29 • Paroxetine hydrochloride (Loxamine) tab 20 mg • Sumatriptan (Arrow-Sumatriptan) tab 50 mg and 100 mg • Brimonidine tartrate (AFT) eye drops 0.2%, 5 ml OP – Retail pharmacy – specialist Changes to restriction (pages 21-26) • Pioglitazone (Actos) tab 15 mg, 30 mg and 45 mg – amended Special Authority criteria Decreased subsidy (page 27-31) • Candesartan (Atacand) tab 4 mg, 8 mg, 16 mg and 32 mg • Sumatriptan (Imigran) tab 50 mg and 100 mg

two new medicines funded for people with hiv infection

Tenofovir disoproxil fumarate 300 mg tablets (Viread) and emtricitabine 200 mg capsules (Emtriva) are new treatments for people with HIV and will be subsidised on the Pharmaceutical Schedule from 1 April 2007. They have similar actions to other anti-HIV medicines that are already subsidised. However, they have some advantages over already subsidised medicines, including once-daily dosing, and are important because the HIV virus can become resistant to existing treatments. Viread may be of particular benefit in patients co-infected with HIV and Hepatitis B. Viread and Emtriva will be subsidised under the same Special Authority criteria as other antiretrovirals.

Pioglitazone – widened access

The Special Authority criteria for pioglitazone tablets (Actos) will be amended from 1 April 2007. The changes will mean the Special Authority can be applied for by any relevant practioner as well as specialists. Other changes include reducing the threshold in HbA1c level, and removing the BMI criterion and allowing practitioner’s discretion to determine obesity in individual patients. See page 21 for details.

New brand of sumatriptan tablets

A new brand of the migraine treatment sumatriptan tablets will be listed from 1 April 2007. The Arrow-Sumatriptan brand will be listed fully subsidised on the Pharmaceutical Schedule without restriction. Also from 1 April 2007 the price and subsidy for Imigran tablets will be reduced but it will remain fully subsidised. PHARMAC does not intend to delist or reference price either brand for at least the next three years.

Paroxetine hydrochloride 20 mg tablets – brand change

The brand of subsidised paroxetine hydrochloride 20 mg tablets is changing from Aropax to Loxamine, as a result of a recent agreement with Pacific Pharmaceuticals. This will result in savings of $45 million over a three year period, which will allow funding of other medications on the Pharmaceutical Schedule. Timelines for this change are as follows: • From 1 April 2007 Loxamine will be available fully subsidised without the need for endorsement, and Aropax will be available fully subsidised by endorsement (as it is now). • From 1 June 2007 the endorsement for full subsidy for Aropax will be removed.

All decisions related to news items are effective from 1 April unless otherwise indicated

The subsidy for Aropax will increase from $1.90 to $5.90 per 30 tablets; however patients would have to pay a part-charge of approximately $54.00 per 30 tablets (plus a co-payment of $15 or $3, as applicable) if the manufacturer’s price for Aropax is not reduced from the current price of $35.02 per 30 tablets. Loxamine will remain fully subsidised. • From 1 September 2007 Loxamine will remain fully subsidised and Aropax will be delisted from the Pharmaceutical Schedule. • From 1 September 2007 Loxamine will be the Sole Subsidised Supply brand of paroxetine hydrochloride 20 mg tablets until 30 June 2010. Aropax and Loxamine tablets both contain 20 mg of paroxetine. In the clinical studies considered by Medsafe during the registration process, Loxamine was demonstrated to be bioequivalent to Aropax, so patients should receive the same benefit from Loxamine as from Aropax. Brand change notification leaflets are available for your patients from PHARMAC. These leaflets help explain the changes to your patients and their caregivers.

Close control and delist date: Calcium Carbonate

The delist date for the Healtheries brand of Calcium Carbonate, Osteo~500 and Osteo~600, has been extended until 1 June 2007. This is to allow residual stock to be cleared from wholesalers and pharmacies. Note that PHARMAC will review the volume of stock still remaining in the supply chain in May 2007, and may extend the delist date if required. Provision for close control monthly for all brands of calcium carbonate 1.25 g and 1.5 g tablets without endorsement from prescriber remains in place. Pharmacies will be notified by fax when this provision is to be removed. Note however, that endorsement of calcium carbonate prescriptions close control monthly is at the discretion of the pharmacist. If sufficient stock is available prescriptions can be dispensed stat.

All decisions related to news items are effective from 1 April unless otherwise indicated

tender News

Sole Subsidised Supply changes – effective 1 May 2007

Chemical Name Amoxycillin Amoxycillin Calcitriol Calcitriol Cyclizine hydrochloride Presentation; Pack size Grans for oral liq 1 mg per ml; 100 ml Grans for oral liq 0 mg per ml; 100 ml Cap 0. µg; 100 cap Cap 0. µg; 100 cap Tab 0 mg; 10 tab Sole Subsidised Supply brand (and supplier) Ranbaxy Amoxicillin (Apotex) Ranbaxy Amoxicillin (Apotex) Calcitriol-AFT (AFT) Calcitriol-AFT (AFT) Nausiclam (AFT)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 may 2007 • Clopidogrel (Plavix) tab 75 mg – subsidy and price decrease to $73.38 per 28 tab • Leflunomide (Arava) tab 10 mg, 20 mg and 100 mg – subsidy and price decrease • Midazolam inj 1 mg per ml, 5 ml and 5 mg per ml, 3 ml - removal of Special Authority

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Acetazolamide Acipimox Acitretin Allopurinol Amitriptyline Amlodipine Apomorphine hydrochloride Amoxycillin Applicator Aqueous cream Ascorbic acid Aspirin Atenolol Atropine sulphate

Presentation

Tab 0 mg Cap 0 mg Cap 10 mg & mg Tab 100 mg & 00 mg Tab 10 mg, mg & 0 mg Tab mg & 10 mg Inj 10 mg per ml, 1 ml Inj 0 mg, 00 mg & 1 g Cap 0 mg & 00 mg Device Cream Tab 100 mg Tab, dispersible 00 mg Tab 0 mg & 100 mg Inj 00 µg, 1 ml Inj 100 µg, 1 ml Eye drops 1% Metered aqueous nasal spray 0 µg Metered aqueous nasal spray 100 µg Scalp app 0.1% Crm 0.1% Oint 0.1% Eye drops 0.% Eye drops 0.% Tab 00 mg Tab mg Suppos 10 mg Tab . mg & 10 mg Inj 0.%, ml Inj 0.%, 8% glucose, ml Tab mg & 10 mg Lotion BP Crm, aqueous, BP Tab dispersible . g Tab 1. g Tab 1. g Inj 0 mg Tab 1. mg, mg & 0 mg

Brand Name Expiry Date*

Diamox Olbetam Neotigason Progout Amitrip Calvasc Mayne Ibiamox Apo-Amoxi Ortho Multichem Apo-Ascorbic Acid Ethics Aspirin Loten AstraZeneca AstraZeneca Atropt Alanase Alanase Beta Scalp Beta Cream Beta Ointment Betoptic Betoptic S Fibalip AFT, Lax-Tabs Fleet Alpha-Bromocriptine Marcain Isobaric Marcain Heavy Pacific Buspirone ABM ABM Calci-Tab Effervescent Calci-Tab 00 Calci-Tab 00 Calcium Folinate Ebewe Apo-Captopril 008 008 008 008 008 008 009 008 00 008 008 009 00 009 009 008 009 009 008 00 008 00 008 00 00 009 008

Beclomethasone dipropionate Betamethasone valerate

Betaxolol hydrochloride Bezafibrate Bisacodyl Bromocriptine mesylate Bupivacaine hydrochloride Buspirone hydrochloride Calamine Calcium carbonate

Calcium folinate Captopril

008 00

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated.

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Cefaclor monohydrate Cefazolin sodium Ceftriaxone sodium Celiprolol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Presentation

Cap 0 mg Grans for oral liq 1 mg per ml Inj 00 mg & 1 g Inj 00 mg & 1 g Tab 00 mg Oral liq 1 mg per ml Tab 10 mg Eye drops 0.% Eye oint 1% Handrub 1% with ethanol 0% Mouthwash 0.% Soln % Tab mg Tab 1. mg (0,000 iu) Tab 0 mg, 00 mg & 0 mg Tab 0 mg Cap hydrochloride 10 mg Inj phosphate 10 mg per ml, ml Crm 0.0% Scalp app 0.0% Oint 0.0% Tab 00 µg & mg TDDS . mg, 100 µg per day TDDS mg, 00 µg per day TDDS . mg, 00 µg per day Tab µg Tab 10 µg Inj 10 µg per ml, 1 ml Vaginal crm 1% with applicators Vaginal crm % with applicators Crm 1% Tab 1 mg, 0 mg & 0 mg Powder for soln for oral use g Oral liq sugar-free trimethoprim 0 mg and sulphamethoxazole 00 mg per ml Tab trimethoprim 80 mg and sulphamethoxazole 00 mg Inj 0 mg per ml, 1 ml Tab 0 mg

Brand Name Expiry Date*

Ranbaxy-Cefaclor Ranbaxy-Cefaclor m-Cefazolin AFT Celol Allerid C Razene Chlorsig Chlorsig Orion Orion Orion Hygroton Cal-d-Forte Cipflox Clarac Dalacin C Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS- Catapres-TTS- Dixarit Catapres Catapres Clomazol Clotrimaderm % Clomazol PSM Enerlyte Trisul 00 008 008 00 008 009 009 008 009 00 008 00 008 009 008 008 008

Chlorthalidone Cholecalciferol Ciprofloxacin Clarithromycin Clindamycin Clobetasol propionate

Clonazepam Clonidine

Clonidine hydrochloride

008

Clotrimazole

00 008 00 00 008

Codeine phosphate Compound electrolytes Co-trimoxazole

Cyclizine lactate Cyproterone acetate

Valoid (AFT) Siterone

008 009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 8

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Cyproterone acetate with ethinyloestradiol Danthron with poloxamer

Presentation

mg with ethinyloestradiol µg tab with inert tablets Oral liq mg with poloxamer 00 mg per ml Oral liq mg with poloxamer 1 g per ml Cap mg & 0 mg Inj 00 mg Nasal spray 10 µg per dose Inj mg per ml, 1 ml Inj mg per ml, ml Range of sizes Tab EC mg & 0 mg Tab long-acting mg & 100 mg Cap 1 mg, 00 mg, 0 mg & 00 mg Tab long-acting 0 mg Tab 0 mg & 0 mg Tab . mg with atropine sulphate µg Tab long-acting 10 mg Tab 0 mg & 10 mg Tab 0 mg with total sennosides 8 mg Tab mg & mg Ointment Tab mg, 10 mg & 0 mg Inj 00 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 00 mg per ml Grans for oral liq 00 mg per ml Tab 00 mg Tab 10 µg Tab µg with norethisterone 00 µg and inert tab Cap 0 mg & 100 mg Tab 0 mg & 0 mg

Brand Name Expiry Date*

Estelle- ED Codalax Codalax Forte Dantrium Mayne Desmopressin-PH&T Mayne Ortho All-flex & Ortho Coil Apo-Diclo Apo-Diclo SR Videx EC DHC Continus Dilzem Diastop Pytazen SR Coloxyl Laxsol Dosan AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin Myambutol New Zealand Medical and Scientific Norimin Vepesid Famox 009 00 008 009 008 009 009 008 00 008 008 008 00 00 008 009 009 009 008 008 009 008 009 00 00 00

Dantrolene sodium Desferrioxamine mesylate Desmopressin Dexamethasone sodium phosphate Diaphragm Dicloflenac sodium Didanosine (DDI) Dihydrocodeine tartrate Diltiazem hydrochloride Diphenoxylate hydrochloride with atropine sulphate Dipyridamole Docusate sodium Docusate sodium with sennosides Doxazosin mesylate Emulsifying ointment BP Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate Ethambutol hydrochloride Ethinyloestradiol Ethinyloestradiol with norethisterone Etoposide Famotidine

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Felodopine Ferrous fumarate Ferrous sulphate Flucloxacillin sodium

Presentation

Tab long-acting mg Tab long-acting 10 mg Tab 00 mg Oral liq 10 mg per ml Cap 0 mg & 00 mg Grans for oral liq 1 mg per ml Grans for oral liq 0 mg per ml Cap 0 mg, 10 mg & 00 mg Oint 950 μg, with fluocortolone pivalate 90 µg and cinchocaine hydrochloride mg per g Suppos 630 μg, with fluocortolone pivalate 10 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 0 mg Tab disp 0 mg, scored Inj 1. mg per 0. ml, 0. ml Inj mg per ml, 1 ml Inj 100 mg per ml, 1 ml Tab 0.8 mg & mg Inj 10 mg per ml, ml Crm % & Oint % Inj 0 mg per ml, ml Tab 80 mg Tab mg Suppos . g TDDS mg and 10 mg Oral pump spray 00 µg per dose Inj mg per ml, 1 ml Inj 0 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Inj 10 iu per ml, ml Tab mg & 0 mg Powder g Rectal foam 10%, CFC-Free Lotn 1% with wool fat hydrous % and mineral oil Inj 0 mg

Brand Name Expiry Date*

Felo ER Felo 10 ER Ferro-tab Ferro-liquid Staphlex AFT AFT Pacific Ultraproct Ultraproct 00 00 00 009

Fluconazole Fluocortolone caproate with fluocortolone pivalate and cinchocaine

008 00

Fluorometholone Fluoxetine hydrochloride Fluphenazine decanoate

Flucon Fluox Fluox Modecate Modecate Modecate Apo-Folic Acid Mayne Foban Pfizer Apo-Gliclazide Minidiab PSM Nitroderm TTS Nitrolingual Pumpspray Serenace Haldol Haldol Concentrate AstraZeneca Douglas m-Hydrocortisone Colifoam Micreme H DP Lotn HC Buscopan

009 00 008

Folic Acid Frusemide Fusidic Acid Gentamicin sulphate Gliclazide Glipizide Glycerol Glyceryl trinitrate Haloperidol Haloperidol decanoate Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrocortisone with wool fat and mineral oil Hyoscine N-butylbromide

009 00 00 009 008 008 00 00 009 008 009 009 008 009 00 008 008

Hydrocortisone with miconazole Crm 1% with miconazole nitrate %

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Hypromellose Ibuprofen Imipramine hydrochloride Indapamide Indomethacin Ipratropium bromide

Presentation

Eye drops 0.% Eye drops 0.% Tab 00 mg Oral liq 100 mg per ml Tab 10 mg & mg Tab . mg Cap mg & 0 mg Aerosol inhaler, 0 µg per dose CFC-free Nebuliser soln 0 µg per 1 ml, 1 ml Nebuliser soln 00 µg per ml, ml Tab long-acting 0 mg Cap 10 mg Cap 0 mg Shampoo % Tab 00 mg Oral liq 10 g per 1 ml Inj . mg & 11. mg Cap 0 mg with benserazide 1. mg Tab dispersible 0 mg with benserazide 1. mg Cap 100 mg with benserazide mg Cap long-acting 100 mg with benserazide mg Cap 00 mg with benserazide 0 mg Inj 0.%, ml Inj 1%, ml Inj 1%, 0 ml Crm .% with prilocaine hydrochloride .% g Crm .% with prilocaine hydrochloride .% 0g Tab mg Oral liq 1 mg per ml Tab 10 mg Tab 1 mg & . mg Paste Inj 9.% Liq 0.% Shampoo 1% Tab mg & mg

Brand Name Expiry Date*

Poly-Tears Methopt I-Profen Fenpaed Tofranil Napamide Rheumacin Atrovent Steri-Neb Steri-Neb Duride Isotane 10 Isotane 0 Ketopine Nizoral Laevolac Lucrin Depot Madopar . Madopar Dispersible Madopar 1 Madopar HBS Madopar 0 Xylocaine 0.% Xylocaine 1.0% Xylocaine 1.0% Emla Emla Nodia Lorapaed Apo-Loratadine Ativan PSM Mayne AFT A-Lices Ludiomil 00 00 009 00 009 00 00 009 00 008 008 00 009 009 008 008 00 009 009 008 00 00 00 009

Isosorbide mononitrate Isotretinoin Ketoconazole Lactulose Leuprorelin Levodopa with benserazide

Lignocaine hydrochloride

Lignocaine with prilocaine hydrochloride

Loperamide hydrochloride Loratadine Lorazepam Magnesium hydroxide Magnesium sulphate Malathion Maldison Maprotiline hydrochloride

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Medroxyprogesterone acetate Mesalazine Methadone hydrochloride Methotrexate

Presentation

Inj 10 mg per ml, 1 ml syringe Enema 1 g per 100 ml Powder 1 g Tab mg Tab . mg & 10 mg Inj 100 mg per ml, ml Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 0 ml Tab 1 mg, 0 mg & 00 mg Tab long-acting 20 mg Tab mg & 0 mg Tab 10 mg Tab mg & 100 mg Crm 0.1% and oint 0.1% Inj 0 mg per ml, 1 ml Inj 0 mg per ml with lignocaine 1 ml Inj 0 mg per ml, 1 ml Inj . mg per ml, 1 ml Inj 00 mg & 1 g Inj mg per ml, ml Tab 10 mg Tab long-acting 00 mg Tab 00 mg & 00 mg Cap 0 mg Cap 0 mg & 00 mg Oral gel 0 mg per g Crm % Tab . mg & mg Tab 00 µg Tab 10 mg & 00 mg Oral liq 1 mg per ml Oral liq mg per ml Oral liq mg per ml Oral liq 10 mg per ml Inj mg per ml, 1 ml Inj 1 mg per ml, 1 ml Cap long-acting 10 mg, 0 mg, 0 mg, 100 mg & 00 mg Tab immediate release 10 mg & 0 mg

Brand Name Expiry Date*

Depo-Provera Pentasa AFT Pallidone Methoblastin Methotrexate Ebewe Methotrexate Ebewe Methotrexate Ebewe Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Metamide Slow-Lopressor Trichozole Metopirone Mexitil Daktarin Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph Mayne Mayne m-Eslon Sevredol 00 009 009 00 009 008

Methyldopa Methylphenidate hydrochloride Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol tartrate Metronidazole Metyrapone Mexiletine hydrochloride Miconazole Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

008 2009 009 009 009 008 008 009

008 00 009 00 009 008 00 008 009 009 009 009

Morphine sulphate

009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Morphine tartrate Nadolol Naphazoline hydrochloride Naproxen

Presentation

Inj 80 mg per ml, 1. ml & ml Tab 0 mg & 80 mg Eye drops 0.1% Tab 0 mg Tab 00 mg Tab long-acting 0 mg Tab long-acting 1000 mg Inj . mg per ml, 1 ml Oral suspension 10 mg per ml Tab 0 mg & 00 mg Tab long-acting 0 mg Jelly % Tab 0 µg Tab mg Tab 00 mg Tab 10 mg & mg Vaginal crm 100,000 u per g with applicators Oral liq 100,000 u per ml Cap 00,000 u Tab 00,000 u Oral liq mg per ml Tab mg Inj mg per ml, ml Inj mg per ml, 10 ml Inj mg per ml, 10 ml Tab 00 mg Suppos 1 mg & 0 mg Oral liq 10 mg per ml Oral liq 0 mg per ml Suppos 00 mg Tab 00 mg with 8 mg codeine Tab 0. mg & 1 mg Tab 100 mg Crm % Tab 0 mg & 100 mg Oral liq benzathine 1 mg per ml Oral liq benzathine 0 mg per ml Eye drops 0.%, 1%, %, %, % & % Tab mg, 10 mg & 1 mg

Brand Name Expiry Date*

Mayne Apo-Nadolol Naphcon Forte Noflam 250 Noflam 500 Naprosyn SR 0 Naprosyn SR 1000 AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Gynol II Noriday 8 Primolut-N Arrow-Norfloxacin Norpress Nilstat Nilstat Nilstat Nilstat Apo-Oxybutynin Apo-Oxybutynin Pamisol Pamisol Pamisol Panadol Panadol Junior Parapaed Six Plus Parapaed Paracare Codalgin Permax Pexsig Lyderm PSM AFT AFT Pilopt Pindol 009 00 008 009 008 00 009 009 009 008 009 008 008 008 009 008 00 00 008

Neostigmine Nevirapine Nicotinic acid Nifedipine Nonoxynol-9 Norethisterone Norfloxacin Nortriptyline Nystatin

Oxybutynin Pamidronate disodium

Paracetamol

008

00 008 008 009 00 00 00 008 00

Paracetamol with codeine Pergolide Perhexiline maleate Permethrin Pethidine hydrochloride Phenoxymethylpenicillin (Penicillin V) Pilocarpine Pindolol

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Poloxamer Potassium chloride

Presentation

Oral drops 10% Tab long-acting 00 mg Inj mg per ml, 10 ml Inj 10 mg per ml, 10 ml Tab 1 mg, mg & mg Tab 1 mg, . mg, mg & 0 mg Oral liq mg per ml Cassette Inj 1. mega u Tab mg Tab 10 mg & 0 mg Cap long-acting 10 mg Tab 0 mg Tab mg, 10 mg & 0 mg Tab 10 mg with hydrochlorothiazide 1. mg Tab 0 mg with hydrochlorothiazide 1. mg Tab 00 mg Tab 00 mg Tab 10 mg & 00 mg Oral liq mg per ml Nebuliser soln, . mg with ipratropium bromide 0. mg Tab mg Crm 1% with chlorhexidine digluconate 0.% Inj 0.9%, ml & 10 ml Grans effervescent g sachets Eye drops % Tab 00 mg Tab EC 00 mg Soln .% with triethanolamine lauryl sulphate and fluorescein sodium Tab 10 mg Tab 0 mg Tab 10 mg Eye Drops 0.% & 0.% Tab 0 mg

Brand Name Expiry Date*

Coloxyl Span-K AstraZeneca AstraZeneca Hyprosin Apo-Prednisone Redipred MDS Quick Card Cilicaine Antinaus Cardinol Cardinol LA Apo-Pyridoxine Accupril Accuretic 10 Accuretic 0 Q 00 Q 00 Arrow Ranitidine Salapin Duolin Apo-Selegiline Silvazine AstraZeneca Ural Cromolux Salazopyrin Salazopyrin EN Pinetarsol Normison Apo-Terbinafine Apo-Timol Apo-Timop Apo-Thiamine 009 008 00 009 009 00 009 00 008 009 008 008 008 009 00 009 008 009 008 00 008 00 009 008 00 00 009 008 008

Prazosin hydrochloride Prednisone Prednisolone sodium phosphate Pregnancy tests - HCG urine Procaine penicillin Prochlorperazine Propranolol Pyridoxine hydrochloride Quinapril Quinapril with hydrochlorothiazide

Quinine sulphate Ranitidine hydrochloride Salbutamol Salbutamol with ipratropium bromide Selegiline hydrochloride Silver sulphadiazine Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terbinafine Timolol maleate Thiamine hydrochloride

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Sole Subsidised Supply Products – cumulative to April 2007

Generic Name

Tranexamic acid Triamcinolone acetonide Triamcinolone acetonide with gramicidin, neomycin and nystatin

Presentation

Tab 00 mg Crm & Oint 0.0% Dental Paste USP 0.1% Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate . mg and gramicidin 0 mcg per g Oint 1 mg with nystatin 100,000 u, neomycin sulphate . mg and gramicidin 0 µg per g Tab 1 µg Tab 0 µg Tab 00 mg Cap mg & 0 mg Cap mg Crm 10% Cap 00 mg Inj 0 mg per ml, 10 ml Tab long-acting 10 mg Inj 1 mg per ml, 1 ml Inj 1 mg per ml, ml Tab (BPC cap strength) Tab, strong, BPC Purified for injection 5 ml & 10 ml Oint BP Cap 0 mg Tab . mg

Brand Name Expiry Date*

Cyklokapron Aristocort Oracort Kenacomb Kenacomb 00 008 009 008

Triazolam Trimethoprim Trimipramine maleate Tropisetron Urea Ursodeoxycholic acid Vancomycin hydrochloride Verapamil hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone April changes are in bold type

Hypam Hypam TMP Tripress Navoban Nutraplus Actigall Pacific Verpamil SR Mayne Mayne Healtheries Apo-B-Complex AstraZeneca Multichem Zincaps Apo-Zopiclone

008 008 008 00 008 008 008 008 009 009 009 00 008 008 008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

New Listings

Effective 1 April 2007

8 HYOSCINE N-BUTYLBROMIDE ❋ Tab 10 mg ................................................................................ 1. GLUCOSE BLOOD DIAGNOSTIC TEST METER - Subsidy by endorsement Meter ...................................................................................... 19.00 0 1 ✓ Gastrosoothe ✓ Accu-Chek Performa

GLUCOSE DEHYDROGENASE The number of test strips available on a prescription is restricted to 0 unless: a) Prescribed with insulin or a sulphonylurea but are on a different prescription and the prescription is endorsed accordingly; or b) Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or c) Prescribed for a pregnant woman with diabetes and endorsed accordingly. Blood/glucose test strips ......................................................... .00 0 test OP ✓ Accu-Chek Performa LISINOPRIL ❋ Tab mg .................................................................................. .8 ❋ Tab 10 mg ................................................................................ .1 ❋ Tab 0 mg ................................................................................ .91 EMTRICITABINE – Special Authority – Hospital pharmacy [HP1] Cap 00 mg .......................................................................... 0.0 Special Authority for subsidy – Form SA09 0 0 0 0 ✓ Arrow-Lisinopril ✓ Arrow-Lisinopril ✓ Arrow-Lisinopril ✓ Emtriva

101

TENOFOVIR DISOPROXIL FUMARATE – Special Authority – Hospital pharmacy [HP1] Tab 00 mg .......................................................................... 1.00 0 Special Authority for subsidy – Form SA09

✓ Viread

111

MORPHINE SULPHATE - Only on a controlled drug form - no patient co-payment payable 1 ✓ Baxter S29 Suppos 10 mg......................................................................... 11.08 PAROXETINE HYDROCHLORIDE Tab 0 mg ................................................................................ .90 SUMATRIPTAN Tab 0 mg ............................................................................. 1.00 Tab 100 mg ............................................................................ 1.00 BRIMONIDINE TARTRATE - Retail pharmacy-specialist ❋ Eye drops 0.% ........................................................................ 8.9 0 ml OP ✓ Loxamine ✓ Arrow-Sumatriptan ✓ Arrow-Sumatriptan ✓ AFT

11 11

Effective 1 March 2007

9 8 LANSOPRAZOLE ❋ Cap 1 mg ................................................................................ .0 HYDROXOCOBALAMIN ❋ Inj 1 mg per ml, 1 ml ............................................................... 10.8 8 ✓ Solox

✓ Goldshield S29

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

New Listings - effective 1 March 2007 (continued)

9 ROXITHROMYCIN Tab 10 mg .............................................................................. 9.0 Tab 00 mg ............................................................................ 18.00 ROPINIROLE HYDROCHLORIDE – Retail pharmacy-specialist ▲ Tab 0. mg x , 0. mg x and 1 mg x 1 ........................ .0 ▲ Tab 0. mg x , 1 mg x and mg x ........................... 1.11 OLANZAPINE - Special Authority - Retail pharmacy Tab . mg ............................................................................. 1.0 Tab mg .............................................................................. 101.1 Tab 10 mg ............................................................................ 0.9 PROMETHAZINE HYDROCHLORIDE ❋ Tab 10 mg ............................................................................... . ❋ Tab mg ................................................................................ .0 0 0 10 OP 1 OP ✓ Arrow-Roxithromycin ✓ Arrow-Roxithromycin ✓ Requip Starter Pack ✓ Requip Follow-on Pack ✓ Zyprexa ✓ Zyprexa ✓ Zyprexa ✓ Allersoothe ✓ Allersoothe

119

8 8 8 0 0

1 18

GLUTEN FREE BREAD MIX - Hospital Pharmacy [HP] - Special Authority Powder ..................................................................................... . 1,000 g OP (.) Special Authority for Subsidy – Form: SA0

Bakels Gluten Free Health Bread Mix

Effective 16 February 2007

10 DICLOFENAC SODIUM - Special Authority available - Retail pharmacy ❋ Tab long-acting mg ............................................................ 19.0 100 ✓ Voltaren SR .10 0 ✓ Diclax SR . 00 ✓ Diclax SR Note – Voltaren SR and Diclax SR 0 pack are to be delisted 1 April 00, and Diclax SR 00 pack is to be delisted 1 August 00.

Effective 1 February 2007

GLUCOSE BLOOD DIAGNOSTIC TEST METER - Subsidy by endorsement Meter ........................................................................................ 9.00 1 ✓ Optium Xceed A diagnostic blood glucose test meter is subsidised for patients who begin insulin or sulphonylurea therapy after 1 March 00. Only one meter per patient. No further prescriptions will be subsidised. The prescription must be endorsed accordingly. DEXTROSE - Available on a PSO ❋ Inj 0%, 90 ml ......................................................................... 11. ADRENALINE Inj 1 in 1,000, 1 ml - Available on a PSO .................................. 1.0 90.00 TESTOSTERONE Transdermal patch . mg per day .......................................... 80.00 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. 1 0 0 ✓ Biomed ✓ AstraZeneca ✓ AstraZeneca ✓ Androderm

▲

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

New Listings - effective 1 February 2007 (continued)

9 11 11 10 ETHAMBUTOL HYDROCHLORIDE - Retail pharmacy-specialist – No patient co-payment payable ❋ Tab 00 mg ............................................................................ 10.98 ✓ Myambutol S29 CITALOPRAM HYDROBROMIDE ❋ Tab 0 mg ................................................................................ .0 LAMOTRIGINE ▲ Tab chewable/dispersible mg................................................ 1.00 ▲ Tab chewable/dispersible mg.............................................. .0 ▲ Tab chewable/dispersible 0 mg.............................................. .0 ▲ Tab chewable/dispersible 100 mg............................................ .90 ▲ Tab chewable/dispersible 00 mg.......................................... 1.0 CLOZAPINE - Hospital pharmacy [HP]-specialist prescription Tab 0 mg .............................................................................. 8.0 Tab 00 mg ............................................................................ 91.0 PIMOZIDE - Retail pharmacy-specialist Tab mg ................................................................................ 11.8 RISPERIDONE - Retail pharmacy-specialist Tab 0. mg ............................................................................... .0 Tab 1 mg ................................................................................ 0. Tab mg ................................................................................ 1. Tab mg ................................................................................ 9. Tab mg .............................................................................. 1.0 8 0 0 ✓ Celapram ✓ Arrow-Lamotrigine ✓ Arrow-Lamotrigine ✓ Mogine ✓ Arrow-Lamotrigine ✓ Mogine ✓ Arrow-Lamotrigine ✓ Mogine ✓ Arrow-Lamotrigine ✓ Mogine ✓ Clopine ✓ Clopine

0 0 0 0 0 0

✓ Orap Forte S29 ✓ Ridal ✓ Ridal ✓ Ridal ✓ Ridal ✓ Ridal

AMINOACID FORMULA WITHOUT PHENYLALANINE - Hospital Pharmacy [HP] - Special Authority Liquid (tropical) ....................................................................... .0 0 ml OP ✓ Easiphen Liquid Special Authority for Subsidy – Form: SA0

Effective 1 January 2007

0 0 CALCIUM CARBONATE ❋ Tab 1. g ................................................................................ .0 100 ❋ Tab 1. g .................................................................................. . 0 Note: Osteo~00 and Osteo~00 were subsidised from 1 December 00. FERROUS FUMARATE WITH FOLIC ACID Tab 10 mg with folic acid 0 µg ............................................ .9 DEXTROSE ❋ Inj 0%, 10 ml - Available on a PSO ......................................... .0 ❋ Inj 0%, 90 ml ....................................................................... 1.00 0 1 ✓ Osteo~500 ✓ Osteo~600

✓ Ferro-F-Tabs ✓ Biomed ✓ Biomed

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

New Listings - effective 1 January 2007 (continued)

SODIUM BICARBONATE – Not in combination Inj 8.%, 0 ml - Available on a PSO ........................................ 19.9 Inj 8.%, 100 ml - Available on a PSO ...................................... 0.0 1 1 ✓ Biomed ✓ Biomed

WATER a) On a prescription or Practitioner’s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent, or b) On a bulk supply order, or c) When used in the extemporaneous compounding of eye drops. Purified for inj 20 ml .................................................................. .0 0 ✓ Multichem OESTRADIOL WITH LEVONORGESTREL ❋ Tab mg with µg levonorgestrel () and mg oestradiol tab (8) ...................................................... 1.0 ACICLOVIR ❋ Tab 00 mg .............................................................................. .9 ACICLOVIR ❋ Tab 00 mg ............................................................................ 11.8

8 98 99 101

8 100 100

✓ Nuvelle ✓ Apo-Acyclovir ✓ Apo-Acyclovir

ABACAVIR SULPHATE WITH LAMIVUDINE - Special Authority - Hospital pharmacy [HP1] Tab 00 mg with lamivudine 00 mg ..................................... 0.00 0 ✓ Kivexa Special Authority for Subsidy - Form: SA09 Note: Kivexa counts as two anti-retroviral medications for the purposes of the anti-retroviral Special Authority. FENTANYL - Only on a controlled drug form - Special Authority - Retail pharmacy – No patient co-payment payable ✓ Durogesic Transdermal patch, matrix µg per hour ............................... . Transdermal patch, matrix 0 µg per hour ............................. 100. ✓ Durogesic Transdermal patch, matrix µg per hour ............................. 19.18 ✓ Durogesic Transdermal patch, matrix 100 µg per hour ........................... 11. ✓ Durogesic Special Authority for Subsidy - Form: SA0 CARBOPLATIN – PCT only - specialist Inj 10 mg per ml, 100 ml ....................................................... 1. CISPLATIN – PCT only – specialist Inj 1 mg per ml, 0 ml ............................................................. 0.00 Inj 1 mg per ml, 100 ml ......................................................... 100.00 FLUOROURACIL SODIUM Inj 0 mg per ml, 10 ml – PCT only – specialist ......................... .0 Inj 0 mg per ml, 0 ml – PCT only – specialist ....................... 10.1 Inj 0 mg per ml, 0 ml – PCT only – specialist ....................... .00 Inj 0 mg per ml, 100 ml – PCT only – specialist ..................... 0.00 SALMETEROL Aerosol inhaler CFC-free, µg per dose ................................. . SODIUM CROMOGLYCATE Nasal spray, % ...................................................................... 1.0 1 1 1 1 1 1 1 ✓ Carboplatin Ebewe ✓ Cisplatin Ebewe ✓ Cisplatin Ebewe ✓ Fluorouracil Ebewe ✓ Fluorouracil Ebewe ✓ Fluorouracil Ebewe ✓ Fluorouracil Ebewe

110

18 18

19 1

10 dose OP ✓ Serevent ml OP ✓ Rex

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

New Listings - effective 1 January 2007 (continued)

18 11 POLYVINYL ALCOHOL ❋ Eye drops 1.% ......................................................................... .9 ❋ Eye drops % ............................................................................ .80 1 ml OP 1 ml OP ✓ Vistil ✓ Vistil Forte ✓ Fortisip Powder

ORAL SUPPLEMENT 1KCAL/ML - Hospital Pharmacy [HP] - Special Authority Powder (vanilla) ...................................................................... 11.0 900 g OP Special Authority for Subsidy – Form: SA08

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Restrictions

Effective 1 April 2007

PIOGLITAZONE - Special Authority - Retail pharmacy Tab 1 mg .............................................................................. 1.0 Tab 0 mg .............................................................................. 9.90 Tab mg ............................................................................ 119.18 Special Authority for Subsidy – Form: SA089 8 8 8 ✓ Actos ✓ Actos ✓ Actos

Initial application for patients with type diabetes only from any relevant practitioner a relevant specialist. Approvals valid for one year for applications meeting the following criteria: Any of the following: Monotherapy 1 All of the following: 1.1 To be used as monotherapy for patients who after six months of diet and lifestyle changes have inadequate glycaemic control (defined as HbA1c > 7.0% in tests carried out at least two months apart); and 1. Metformin is contraindicated or not tolerated after a minimum of a four week trial period; and 1. Sulphonylurea is contraindicated or not tolerated or the patient is obese patient’s body mass index (BMI) exceeds kg/m); or In combination with sulphonylurea Both: .1 For use in combination with a sulphonylurea for patients who after diet and lifestyle changes and a six month trial of sulphonylurea have poor glycaemic control (defined as HbA1c > 7.5 8.0% measured within the last month of the six month period); and . Metformin is contraindicated or not tolerated after a minimum of a four-week trial period; or In combination with metformin Both: .1 For use in combination with metformin for patients who after diet and lifestyle changes and a six-month trial of the maximum tolerated dose of metformin have poor glycaemic control (defined as HbA1c > 7.5 8.0% measured within the last month of the six month period); and . Sulphonylurea is contraindicated or not tolerated or the patient is obese patient’s body mass index (BMI) exceeds kg/m); or In combination with metformin after a trial of metformin and sulphonylurea For use in combination with metformin for patients who after diet and lifestyle changes and a six-month trial of a combination of metformin and sulphonylurea at maximum tolerated doses have poor glycaemic control (defined as HbA1c > 7.5 8.0% measured within the last month of the six month period); or In combination with insulin For use in combination with insulin in patients requiring more than 1. units per kilogram of insulin a day for atleast months in conjunction with metformin if tolerated. Note Pioglitazone is not to be used in triple oral combination (defined as a combination of metformin, sulphonylurea and pioglitazone) Pioglitazone should not be used in patients with heart failure. Liver function tests should be performed at baseline. Gastrointestinal side effects are relatively common when initiating metformin therapy. Upward titration of metformin dose over several weeks and taking metformin with food will help to minimize these side effects. Intolerance and contraindications for metformin include: i) Serum creatinine ≥ 0.15 or creatinine clearance < 60 ml/min ii) Significant liver impairment iii) Severe left ventricular dysfunction iv) Intolerable gastrointestinal side effects that persist beyond weeks duration. continued...

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Restrictions - effective 1 April 2007 (continued)

continued... Intolerance for sulphonylurea includes: nausea; diarrhoea; rash; blood disorders (thrombocytopenia, agranulocytosis, aplastic anaemia); erythema multiforme, exfoliative dermatitis, hepatitis; and syndrome of inappropriate antidiuretic hormone secretion (SIADH) with water retention and hyponatraemia. Maximum tolerated dose of metformin defined as: A dose up to a maximum of 3 g daily. Maximum tolerated dose of sulphonylurea defined as: A dose up to a maximum of glibenclamide 20 mg daily or glipizide 0 mg daily or gliclazide 0 mg daily. For the purposes of these criteria “obese” is defined as body mass index (BMI) greater than 33 kg/m2. However, as ethnic differences between patients may vary BMI scores, practitioners may use discretion as to whether the patient meets this criterion. It is considered that when applying under criterion 1.1, that the patient may have initiated “six months diet and lifestyle changes” from the date of diagnosis of type 2 diabetes. Renewal for patients with type diabetes only from any relevant practitioner a relevant specialist or general practitioner. Approvals valid for one year for patients who are applications meeting the following criteria: Both: continuing to derive benefit from treatment Patient has had two consecutive HbA1c levels test results of < 8.0 % (at least two months apart) in the last six-month period of pioglitazone treatment and Either: .1 The patient is not on insulin combination therapy; or . Following the addition of pioglitazone, there has been at least a 0% reduction in insulin dosage

Effective 1 March 2007

8 9 HYDROCORTISONE WITH WOOL FAT AND MINERAL OIL - Only on a the prescription of a doctor Lotn 1% with wool fat hydrous % and mineral oil ..................... 9.9 0 ml ✓ DP Lotn HC GLYCEROL WITH PARAFFIN AND CETYL ALCOHOL - Only on a the prescription of a doctor ❋ Lotn 5% with paraffin liq 5% and cetyl alcohol 2% ..................... 1.0 0 ml (8.10) QV WOOL FAT WITH MINERAL OIL - Only on a the prescription of a doctor Lotn hydrous % with mineral oil ............................................... 1.1 (.00) Lotn hydrous % with mineral oil ............................................... 1.0 (.8) (.9) (.) Lotn hydrous % with mineral oil ............................................... .10 (9.8) Lotn hydrous % with mineral oil ............................................... .0 (9.8) (9.) (18.) (.91) 00 ml OP Alpha-Keri Lotion 0 ml OP DP Lotion Hydroderm Lotion BK Lotion ml OP Alpha-Keri Lotion 1,000 ml DP Lotion Hydroderm Lotion Alpha-Keri Lotion BK Lotion

TAR WITH TRIETHANOLAMINE LAURYL SULPHATE AND FLUORESCEIN - Only on a the prescription of a doctor ❋ Soln .% with triethanolamine lauryl sulphate and fluorescein sodium ......................................................... .0 00 ml ✓ Pinetarsol

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Restrictions - effective 1 March 2007 (continued)

98 VALACICLOVIR HYDROCHLORIDE Tab 00 mg ............................................................................ . 1.80 Note: Valtrex tab 00 mg is now a registered medicine. 10 0 ✓ Valtrex S29 ✓ Valtrex S29

CYCLIZINE HYDROCHLORIDE - Special Authority available - Retail pharmacy Tab 0 mg ................................................................................ 1. 10 (.0) Marzine Special Authority for Manufacturers Price - Form: SA018 Note: The alternate subsidy by Special Authority for Marzine tab 0 mg is for the Manufacturers Price. SELEGILINE HYDROCHLORIDE - Retail pharmacy-specialist ❋ Tab mg ................................................................................ 1.0 100 ✓ Apo-Selegiline Note: Due to uncertainty around the long term effects of Selegiline it is not recommended as a first line agent. TRIFLUOPERAZINE HYDROCHLORIDE Tab mg ................................................................................ 1. 100 Stelazine S29 (1.1) Tab mg ................................................................................ 1.9 100 Stelazine S29 (1.) Note: Stelazine tab mg and mg, 100 tab packs are now supplied under Section 9 of the Medicines Act 1981. CYCLOPHOSPHAMIDE Inj 1 g – Retail pharmacy-specialist - PCT PCT only – specialist ........................................................... 1.1 MULTIPLE SCLEROSIS TREATMENT GLATIRAMER ACETATE – Access by application Inj 20 mg pre-filled syringe ................................................. 1,089. INTERFERON BETA-1-ALPHA - Access by application Inj million iu per vial ......................................................... 1,1.0 INTERFERON BETA-1-BETA - Access by application Inj 8 million iu per 1 ml ...................................................... 1,.09

119 1

✓ Endoxan

8 1

✓ Copaxone ✓ Avonex ✓ Betaferon

Access by application a) Budget managed by appointed clinicians on the Multiple Sclerosis Treatment Assessments Committee (MSTAC). b) Applications will be considered by MSTAC at its regular meetings and approved subject to eligibility according to the Entry and Stopping criteria (below). c) Applications to be made on the approved forms which are available from the co-ordinator for MSTAC: The Co-ordinator Multiple Sclerosis Treatment Assessments Committee PHARMAC, PO Box 10 Wellington Email silvia.valsenti@pharmac.govt.nz mstaccoordinator@pharmac.govt.nz Phone: (0) 0 990 Facsimile: (0) 91 1 d) Completed application forms must be sent to the co-ordinator for MSTAC and will be considered by MSTAC at the next practicable opportunity. continued...

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Restrictions - effective 1 March 2007 (continued)

continued... e) Notification of MSTAC’s decision will be sent to the patient, the applying clinician and the patient’s GP (if specified). f) These agents will NOT be subsidised if dispensed from a community or hospital pharmacy. Regular supplies will be distributed to all approved patients or their clinicians by courier. g) Prescribers must fax send quarterly prescriptions for approved patients to the MSTAC co-ordinator. h) Only prescriptions for million iu of interferon beta-1- alpha per week, or 8 million iu of interferon beta-1-beta every other day, or 20 mg glatiramer acetate daily will be subsidised. i) Appeals against MSTAC’s decision and/or the processing of any application may be lodged with the MSTAC co-ordinator. Concerns that cannot be or have not been adequately addressed by MSTAC will be forwarded to a separate Appeal Committee if necessary. j) Switching between treatments is permitted within the 12 month approval period without reapproval by MSTAC. The MSTAC co-ordinator should be notified of the change and a new prescription provided. k) Entry and Stopping criteria Entry Criteria • Diagnosis of multiple sclerosis (MS) must be confirmed by a neurologist. Diagnosis should as a rule include MRI confirmation. For patients diagnosed before MRI was widely utilised in New Zealand, confirmation of diagnosis via clinical assessment and laboratory/ancillary data must be provided; and • patients must have active relapsing MS (confirmed by MR scan where necessary) with or without underlying progression; and • patients must have either: 1. EDSS score . - . with + relapses: - experienced at least 2 significant relapses of MS in the previous 12 months, and - an EDSS score of between . and . inclusive; or . EDSS score .0 with + relapses: - experienced at least 3 significant relapses of MS in the previous 12 months, and - an EDSS score of .0; and • Each relapse must: - be confirmed by a neurologist or general physician (the patient may not necessarily have been seen during the relapse but the neurologist/physician must be satisfied that the clinical features were characteristic and met the specified criteria); - be associated with characteristic new symptom(s)/sign(s) or substantial worsening of previously experienced symptom(s)/sign(s); - last at least one week; - follow a period of stability of at least one month; - be severe enough to change either the EDSS or at least one of the Kurtzke functional systems scores by at least 1 point; - be distinguishable from the effects of general fatigue; and - not be associated with a fever (T>37.5oC); and • applications must be made at least four weeks after the date of the onset of the last known relapse; and • patients must have no previous history of lack of response to beta-interferon and or glatiramer acetate (see criteria for stopping beta-interferon). • applications must be submitted to the Multiple Sclerosis Treatment Assessment Committee (MSTAC) by the patient’s neurologist or a general physician; and • patients must agree (via informed consent) to co-operate if as a result of their meeting the stopping criteria, funding is withdrawn. Patients must agree to the collection of clinical data relating to their MS and use of those data by PHARMAC; and • patients must agree to allow clinical data to be collected and reviewed by MSTAC annually for each year in which they receive funding for beta-interferon or glatiramer acetate.

continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

S29

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Restrictions - effective 1 March 2007 (continued)

continued... Stopping Criteria • Confirmed progression of disability that is sustained for three months after a minimum of one year of treatment. Progression of disability is defined as either an increase of 1 EDSS point from the starting EDSS or an increase in EDSS score to .0 or more; or • stable or increasing relapse rate over 1 months of treatment (compared with the relapse rate on starting treatment); or • pregnancy and/or lactation; or • within the 12 month approval year, intolerance to interferon beta-1-alpha, and/or interferon beta-1-beta and/or glatiramer acetate; or • non-compliance with treatment, including refusal to undergo annual assessment or refusal to allow the results of the assessment to be submitted to MSTAC; or • patients may, subject to conclusions drawn from published evidence available at the time, be excluded if they develop a high titre of neutralising anti-bodies to beta-interferon or glatiramer acetate. 1 SPACER DEVICES AND MASKS - Only on a WSO a) Only on a WSO b) Maximum of 20 per WSO Spacer device.......................................................................... 1.0 Mask, size .............................................................................. .10 a) b) c) d)

✓ Space Chamber ✓ Foremount Child’s Silicone Mask Spacer devices and masks also available to paediatricians employed by a DHB on a wholesale supply order signed by the paediatrician. Limited to one pack of 0 per order. Orders via a hospital pharmacy. Only available for children aged six years and under. For Space Chamber and Foremount Child’s Silicone Mask wholesale supply order must indicate clearly if either the spacer device, the mask, or both are required. Distributed by Airflow Products. Forward orders to: Airflow Products Telephone: 04 499 1240 or 0800 AIR FLOW PO Box 18, Wellington Facsimile: 0 99 1 or 0800 0

1 OP 1 OP

Effective 1 February 2007

9 CARVEDILOL - Special Authority - Retail pharmacy Tab . mg ........................................................................... 1.00 0 ✓ Dilatrend Tab 1. mg ........................................................................... .00 0 ✓ Dilatrend Tab mg .............................................................................. . 0 ✓ Dilatrend Special Authority for Subsidy - Form: SA0 Initial application only from a general practitioner or relevant specialist. Approvals valid without further renewal unless notified for applications meeting the following criteria: Both: 1 Patient is already on an ACE inhibitor or Angiotensin II Antagonist; and Any of the following: .1 Both: .1.1 Symptomatic heart failure NYHA functional class II-II; and .1. Patient has been treated with metoprolol and is intolerant to metoprolol or has demonstrated a sub-optimal response to metoprolol; or . Symptomatic heart failure NYHA functional class II-IV; or . Patient has left ventricular systolic dysfunction with an ejection fraction of less than %. Note: Where possible treatment should be initiated by or on the recommendation of a specialist.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Restrictions - effective 1 February 2007 (continued)

19 CYTARABINE Inj 100 mg per ml, 5 ml 00 mg - Retail pharmacy-specialist – PCT ...................................... 9. Inj 100 mg per ml, 10 ml 1 g - Retail pharmacy-specialist – PCT ...................................... .

✓ Mayne ✓ Mayne

CHARCOAL ❋ Oral liq 0 g per 0 ml – Only on a PSO ................................. . 0 ml OP ✓ Carbosorb-X S29 Note: Because activated charcoal is used in acute poisonings, patient details required under Section 9 of the Medicines Act may be retrospectively provided to the supplier. GLYCEROL - Only in combination ❋ Liquid ...................................................................................... . ,000 ml ✓ MidWest ✓ PSM (Only in extemporaneously compounded oral liquid preparations methadone mixture, codeine linctus diabetic, codeine linctus paediatric or phenobarbitone oral liquid)

Effective 1 January 2007

9 POVIDONE IODINE Alcohol skin preparation 10% .................................................... 8.1 (1.9) Skin preparation, povidone iodine 10% with 0% alcohol ............ 8.1 Skin preparation, povidone iodine 10% with 0% alcohol ............ 8.1 (1.9) Note: this is a description change only. NYSTATIN Tab 00,000 u .......................................................................... 9.0 ACICLOVIR ❋ Tab dispersible 00 mg ........................................................... 8. 90 ✓ Zovirax S29 Zovirax tab dispersible 00 mg now has Ministerial consent for distribution, so Section 9 criteria no longer applies. 1 TRIFLUOPERAZINE HYDROCHLORIDE Tab 1 mg .................................................................................. 9.8 (10.) 100 Stelazine S29 00 ml 00 ml 00 ml ✓ Betadine Skin Prep Orion ✓ Betadine Skin Prep Orion

✓ Nilstat S29

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 April 2007

APROTININ - Hospital pharmacy [HP]-specialist (è price) ❋ Inj 10,000 µg per ml 0 ml ...................................................... .0 (.0) HEPARIN SODIUM (è price) Inj ,000 iu per ml, ml .......................................................... .0 (.) CANDESARTAN - Special Authority - Retail pharmacy (ê subsidy) ❋ Tab mg ................................................................................ 1. No more than 1. tabs per day ❋ Tab 8 mg ................................................................................ 19.0 No more than 1. tabs per day ❋ Tab 1 mg .............................................................................. . No more than 1 tab per day ❋ Tab mg .............................................................................. 8.0 No more than 1 tab per day Special Authority for Subsidy - Form: SAQQQQ BETAMETHASONE VALERATE WITH FUSIDIC ACID (è price) a) Only on a prescription; b) Maximum 1 g per prescription. Crm 0.1% with fusidic acid % ................................................. .9 (8.8) SUMATRIPTAN (ê subsidy) Tab 0 mg .............................................................................. .00 Tab 100 mg ............................................................................ .00 FUSIDIC ACID (è price) Eye drops 1% ........................................................................... .0 (9.8) 1 Trasylol 10 Multiparin 0 0 0 0 ✓ Atacand ✓ Atacand ✓ Atacand ✓ Atacand

1 g OP Fucicort g OP Fucithalmic ✓ Imigran ✓ Imigran

Effective 1 March 2007

CHOLINE SALICYLATE WITH CETALKONIUM CHLORIDE (è price) ❋ Adhesive gel 8.% with cetalkonium chloride 0.01% ................. .0 (.) 1 g OP Bonjela

WATER (ê subsidy) a) On a prescription or Practitioner’s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent, or b) On a bulk supply order, or c) When used in the extemporaneous compounding of eye drops. Purified for inj 20 ml .................................................................. . 0 (1.00) Pharmacia

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 March 2007 (continued)

OXYTOCIN - Available on a PSO Inj iu per ml, 1 ml (ê subsidy) ................................................. .0 Inj 10 iu per ml, 1 ml (ê subsidy) ............................................... .80 Inj iu with ergometrine maleate 00 µg per ml, 1 ml (è subsidy) .................................................................... 9.0 ✓ Syntocinon ✓ Syntocinon ✓ Syntometrine

FUSIDIC ACID (è price) Inj 00 mg sodium fusidate per 10 ml ...................................... 1.8 1 (1.80) Fucidin a) Hospital pharmacy [HP] - Specialist b) Subsidy by endorsement Only if prescribed for a dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. CISPLATIN – PCT only – specialist (ê subsidy) Inj 1 mg per ml, 0 ml ............................................................. 19.00 Inj 1 mg per ml, 100 ml ........................................................... 8.00 SODIUM CROMOGLYCATE (ê subsidy) Nasal spray, % ..................................................................... 1.0 1 1 ml OP ✓ Cisplatin Ebewe ✓ Cisplatin Ebewe ✓ Rynacrom Forte

Effective 1 February 2007

8 8 9 0 8 HYDROGEN PEROXIDE (è subsidy) ❋ Soln 10 vol ................................................................................ 1.8 a) maximum 00 ml per prescription THYMOL GLYCERIN (è subsidy) ❋ Compound, BPC ........................................................................ 9.1 CALCITRIOL - Retail pharmacy-specialist (ê subsidy) ❋ Cap 0. µg ............................................................................ 1. (.) ❋ Cap 0. µg .............................................................................. .9 (8.98) SODIUM FLUORIDE (è subsidy) Tab 1.1 mg ............................................................................... .00 SIMVASTATIN - See Prescribing Guideline (ê subsidy) ❋ Tab 10 mg ................................................................................ 8. ❋ Tab 0 mg .............................................................................. 10.1 ❋ Tab 0 mg .............................................................................. 18.00 ❋ Tab 80 mg .............................................................................. 1.00 100 ml ✓ PSM

00 ml 100

✓ PSM

Rocaltrol 100 Rocaltrol 100 0 0 0 0 ✓ PSM ✓ Lipex ✓ Lipex ✓ Lipex ✓ Lipex

MENTHOL - Only in combination (ê price) Crystals..................................................................................... .0 g ✓ PSM a) Only in combination with aqueous cream, 10% urea cream, wool fat with mineral oil lotion, 1% hydrocortisone with wool fat and mineral oil lotion, and glycerol, paraffin and cetyl alcohol lotion. CETOMACROGOL (è subsidy) ❋ Cream BP .................................................................................. . 00 g ✓ PSM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 February 2007 (continued)

9 0 GAMMA BENZENE HEXACHLORIDE (è subsidy) Crm 1% .................................................................................... .0 0 g OP ✓ Benhex

COAL TAR - Only in combination (è subsidy) Soln BP ................................................................................... .8 00 ml ✓ PSM a) Up to 10%; b) Only in combination with a dermatological base or proprietary Topical Corticosteroid - Plain; (refer page 10) c) With or without other dermatological galenicals. SALICYLIC ACID - Only in combination (è subsidy) Powder ................................................................................... 18.88 0 g ✓ PSM a) Only in combination with a dermatological base or proprietary Topical Corticosteroid - Plain or collodian flexible; (refer page 160) b) With or without other dermatological galenicals. c) Maximum 20 g or 20 ml per prescription when prescribed with white soft paraffin or collodian flexible. AMOXYCILLIN (ê subsidy) Grans for oral liq 1 mg per ml - Available on a PSO ............. 1.00 (1.08) Grans for oral liq 0 mg per ml - Available on a PSO ............. 1. (1.8) METRONIDAZOLE (è subsidy) Oral liq benzoate 00 mg per ml ........................................... .00 100 ml Ospamox 100 ml Ospamox 100 ml ✓ Flagyl - S ✓ PSM ✓ D-Penamine ✓ D-Penamine ✓ Dopress

9 9 10

ISONIAZID - Retail pharmacy-specialist – No patient co-payment payable (ê subsidy) ❋ Tab 100 mg ............................................................................ 0.0 100 PENICILLAMINE - Retail pharmacy-specialist (è subsidy) Tab 1 mg ............................................................................ 1.9 Tab 0 mg ............................................................................ 98.98 DOTHIEPIN HYDROCHLORIDE (è subsidy) Cap mg ................................................................................ . 100 100 100

11 11

CYCLIZINE HYDROCHLORIDE - Special Authority available - Retail pharmacy (ê alternate subsidy) Tab 0 mg ................................................................................ 1. 10 (.0) Marzine Special Authority for Manufacturers Price - Form: SA018 Note: The alternate subsidy by Special Authority for Marzine tab 0 mg will be $1.99 per 10 tablets. DEXAMPHETAMINE SULPHATE (ê subsidy) a) Special Authority - Retail pharmacy b) Controlled Drug Form Tab mg ................................................................................ 18.00 Special Authority for Subsidy - Form: SA09 CISPLATIN – PCT only – specialist (ê subsidy) Inj 1 mg per ml, 0 ml ............................................................. 19.00 Inj 1 mg per ml, 100 ml ........................................................... 8.00

100

✓ PSM

1 1

✓ Mayne ✓ Mayne

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 February 2007 (continued)

19 CYTARABINE (ê subsidy) Inj 100 mg per ml, ml - Retail pharmacy-specialist – PCT ..... 9. Inj 100 mg per ml, 10 ml - Retail pharmacy-specialist – PCT ... . Inj 100 mg per ml, 0 ml - PCT only – specialist ...................... . ETOPOSIDE (ê subsidy) Inj 0 mg per ml, ml - Hospital pharmacy [HP1] - specialist – PCT ................................................................ .00 INTERFERON BETA-1-BETA - Access by application (è subsidy) Inj 8 million iu per 1 ml ...................................................... 1,.09 NALOXONE HYDROCHLORIDE - Only on a PSO (è subsidy) ❋ Inj 00 µg per ml, 1 ml ............................................................ .00 CHLOROFORM - Only in combination (è subsidy) Chloroform BP......................................................................... .0 (Only in aspirin and chloroform application) COLLODION FLEXIBLE (è subsidy) .............................................. 19.0 GLYCEROL - Only in combination (ê price) ❋ Liquid ...................................................................................... . (Only in extemporaneously compounded oral liquid preparations) 1 1 ✓ Mayne ✓ Mayne ✓ Mayne

1 1 00 ml 100 ml ,000 ml

✓ Mayne ✓ Betaferon ✓ Mayne ✓ PSM ✓ PSM ✓ PSM ✓ PSM

1 19 1

1 1 1

PROPYLENE GLYCOL (è subsidy)................................................ 1.0 00 ml (Only in extemporaneously compounded methylhydroxybenzoate 10% solution)

Effective 1 January 2007

1 INSULIN ASPART (ê subsidy) ▲ Inj 100 u per ml, ml .............................................................. . ▲ Inj 100 u per ml, 10 ml ............................................................ 1. MUCILAGINOUS LAXATIVES WITH STIMULANTS (è price) ❋ Dry............................................................................................ .0 (1.00) DEXTROSE (è subsidy) ❋ Inj 0% 10 ml - Available on a PSO ............................................ 8. BETAMETHASONE DIPROPIONATE (è price) Crm 0.0% ............................................................................... .9 (.91) Crm 0.0% in propylene glycol base .......................................... . (1.8) Oint 0.0% in propylene glycol base .......................................... . (1.8) 1 0 g OP Granocol 1 g OP Diprosone 0 g OP Diprosone OV 0 g OP Diprosone OV ✓ Mayne ✓ NovoRapid Penfill ✓ NovoRapid

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 January 2007 (continued)

1 PODOPHYLOTOXIN (è price) Soln 0.% ............................................................................... .00 (8.00) a) Only on a prescription; b) Maximum . ml per prescription. OXYTOCIN - Available on a PSO (è subsidy) Inj iu per ml, 1 ml ................................................................... 9.88 Inj 10 iu per ml, 1 ml ............................................................... 1. OESTRADIOL (è price) ❋ TDDS .9 mg per day (releases 0 µg of oestradiol per day) ...... .1 (1.0) a) Only on a prescription; b) No more than 1 patch per week; c) Higher subsidy of $1.18 per with Special Authority. OESTRADIOL (è price) ❋ TDDS .8 mg per day (releases 100 µg of oestradiol per day) .... .0 (1.) a) Only on a prescription; b) No more than 1 patch per week; c) Higher subsidy of $1.1 per with Special Authority. . ml OP Condyline

✓ Syntocinon ✓ Syntocinon

Climara 0

Climara 100

10 11

DICLOFENAC SODIUM - Special Authority available - Retail pharmacy (è price) ❋ Tab 0 mg dispersible ............................................................... 1.0 0 (8.00) CYCLIZINE HYDROCHLORIDE - Special Authority available - Retail pharmacy (è price) Tab 0 mg ................................................................................ 1. 10 (.0) METHYLPHENIDATE HYDROCHLORIDE (ê subsidy) a) Special Authority - Retail pharmacy b) Controlled Drug Form Tab long-acting 0 mg ............................................................ .0 Special Authority for Subsidy - Form: SA09 CISPLATIN – PCT only – specialist (ê subsidy) Inj 1 mg for ECP ........................................................................ 1. CHARCOAL (è subsidy) ❋ Oral liq 0 g per 0 ml – Only on a PSO ................................. .

Voltaren D

Marzine

100

✓ Ritalin SR

18 19

1 mg

✓ Baxter

0 ml OP ✓ Carbosorb-X S29

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to General Rules

Effective 1 March 2007

1 Hospital Pharmaceutical and Pharmaceutical Cancer Treatment costs The cost of purchasing Hospital Pharmaceuticals and Pharmaceutical Cancer Treatments (for use in DHB hospitals and/or in association with Outpatient services provided in DHB hospitals) is met by the Funder (in particular, the relevant DHB) from its own budget. As required by section () of the Act, in performing any of their functions in relation to the supply of Pharmaceuticals, including Pharmaceutical Cancer Treatments, DHBs must not act inconsistently with the Pharmaceutical Schedule. “Hospital Pharmacy” means that the Community Pharmaceutical is not eligible for Subsidy unless it is supplied by a hospital or pharmacy contracted to the Funder to dispense as a hospital pharmacy to an person Outpatient on the Prescription of a Practitioner Doctor. “Hospital Pharmacy-Dermatologist” means that the Community Pharmaceutical is not eligible for Subsidy unless it is supplied by a hospital or pharmacy contracted to the Funder to dispense as a hospital pharmacy: a) to an Outpatient; and b) on a Prescription signed by a Specialist in dermatology

Changes to Brand Name

Effective 1 March 2007

18 AMINOACID FORMULA WITHOUT VALINE, LEUCINE AND ISOLEUCINE - Hospital Pharmacy [HP] - Special Authority Powder ................................................................................. 0. 00 g OP ✓ MSUD Maxamaid Maxamaid MSUD . ✓ MSUD Maxamum Maxamum MSUD 8.8 ✓ MSUD Aid III MSUD Aid AMINOACID FORMULA WITHOUT PHENYLALANINE - Hospital Pharmacy [HP] - Special Authority Infant formula ........................................................................ 1.0 00 g OP ✓ XP Analog LCP Analog LCP Powder (orange) .................................................................. 19.00 00 g OP ✓ XP Maxamaid Maxamaid XP 0.00 ✓ XP Maxamum Maxamum XP Powder (unflavoured) ........................................................... 19.00 00 g OP ✓ XP Maxamaid Maxamaid XP 0.00 ✓ XP Maxamum Maxamum XP

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Changes to Brand Name - effective 1 February 2007

9 COLISTIN SULPHOMETHATE a) Hospital pharmacy [HP]-specialist b) Subsidy by endorsement Only if prescribed for a dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 10 mg .............................................................................. 9. 1 ✓ Colistin-Link Colymycin-M

Changes to Sole Subsidised Supply

Effective 1 April 2007

For the list of new Sole Subsidised Supply products effective 1 April 00 refer to the bold entries in the cumulative Sole Subsidised Supply table pages -1.

Changes to PSO

Effective 1 February 2007

191 Blood and Blood Forming Organs Dextrose Inj 0%, 90 ml

Effective 1 January 2007

191 Blood and Blood Forming Organs Sodium bicarbonate Inj 8.%, 0 ml Inj 8.%, 100 ml

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Delisted Items

Effective 1 April 2007

8 10 1 ATROPINE SULPHATE ❋ Inj 00 µg, 1 ml - Available on a PSO ...................................... 9.9 BISACODYL - Only on a prescription ❋ Tab mg .................................................................................. . DICLOFENAC SODIUM - Special Authority available - Retail pharmacy, ❋ Tab long-acting mg ............................................................ 19.0 .10 METHYLPHENIDATE HYDROCHLORIDE a) Special Authority - Retail pharmacy b) Controlled Drug Form Tab long-acting 0 mg ............................................................ .0 Special Authority for Subsidy - Form: SA09 0 00 ✓ AstraZeneca ✓ AFT

100 0

✓ Voltaren SR ✓ Diclax SR

100

✓ Ritalin SR

INTERFERON ALPHA-A - Hospital pharmacy [HP] – PCT – specialist Inj 18 m iu multidose cartridge starter pack ............................ 18.9 1 Only one multidose cartridge starter pack to be prescribed and dispensed per patient. Note – Roferon-A inj 18 m iu multidose cartridge x starter pack remains subsidised. ATROPINE SULPHATE ❋ Eye drops 0.% ........................................................................ .0 FAT SUPPLEMENT - Hospital Pharmacy [HP] - Special Authority Oil ........................................................................................... 9. Special Authority for Subsidy – Form: SA080 1 ml OP

✓ Roferon-A

1 19

✓ Atropt

1,000 ml OP ✓ Liquigen

Effective 1 March 2007

MUCILAGINOUS LAXATIVES - Only on a prescription ❋ Dry............................................................................................ .8 NICOTINIC ACID ❋ Tab 00 mg ............................................................................ 1.1 CALAMINE a) Not in combination; and b) Only on a prescription. Lotn, BP .................................................................................. 19. (.9) 1.9 (.) 0.9 (.00) 00 g OP ✓ Mucilax

100

✓ Niacin-Odan S29

,000 ml PSM 00 ml PSM 100 ml PSM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Delisted Items - effective 1 March 2007 (continued)

90 CEFAMANDOLE NAFATE a) Hospital pharmacy [HP]-specialist b) Subsidy by endorsement Only if prescribed for a dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 00 mg ................................................................................ .0 1 (.0) Mandol Inj 1 g ....................................................................................... .0 1 ✓ Mandol CEPHALEXIN MONOHYDRATE - Hospital pharmacy [HP] Cap 0 mg .............................................................................. .00 FLUCONAZOLE - Hospital pharmacy [HP]-specialist Cap 00 mg .......................................................................... .9 NAPROXEN - Special Authority available - Retail pharmacy ❋ Tab 0 mg ............................................................................ 1.00 ❋ Tab 00 mg ............................................................................ .90 0 8 00 00 ✓ Keflex ✓ Diflucan ✓ Naxen ✓ Naxen

91 9 10

Effective 1 February 2007

POLYSILOXANE ❋ Tab aluminium hydroxide 0 mg with magnesium trisil 10 mg, magnesium hydroxide 10 mg and polysiloxane 10 mg.............................................................. 1.00 (18.0) INSULIN ISOPHANE ▲ Inj human 100 u per ml, ml ................................................... 9.8 ▲ Inj human 100 u per ml .......................................................... 1.8 INSULIN ISOPHANE WITH INSULIN NEUTRAL ▲ nj human with neutral insulin 100 u per ml, ml ..................... . I ▲ Inj human with neutral insulin 100 u per ml .............................. .

00 Gastrogel 10 ml OP 10 ml OP ✓ Humulin N ✓ Humulin N ✓ Humulin 0/0 ✓ Humulin 0/0

0 0

DANTHRON WITH POLOXAMER - Only on a prescription Note: Danthron with poloxamer is only approved for the prevention or treatment of constipation in the terminally ill. Studies in rats have associated use of danthron with tumours. Oral liq mg with poloxamer 00 mg per ml ......................... .00 00 ml ✓ Codalax Oral liq mg with poloxamer 1g per ml ................................. 8.0 00 ml ✓ Codalax Forte ASCORBIC ACID a) No more than 100 mg per dose b) Only on a prescription ❋ Tab 100 mg ............................................................................ 1.00 (1.) .0 (.) SIMVASTATIN - See Prescribing Guideline ❋ Tab mg .................................................................................. 9.0

00 Alpha Ascorbic Acid 100 Apo-Ascorbic Acid 0 ✓ Zocor

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Delisted Items - effective 1 February 2007 (continued)

CALAMINE a) Not in combination; and b) Only on a prescription. Crm, aqueous, BP ................................................................... 1.10 (1.) TINIDAZOLE Tab 00 mg ............................................................................ 1. FLUPHENAZINE DECANOATE - Retail pharmacy-specialist Inj mg per ml, ml - Available on a PSO ............................. 9.0 DIPIVEFRIN HYDROCHLORIDE - Retail pharmacy-specialist ▲ Eye drops 0.1% ........................................................................ .0

00 g PSM 0 10 ml OP ✓ Dyzole ✓ Mayne ✓ Propine

9 1 1

Effective 1 January 2007

8 DICYCLOMINE HYDROCHLORIDE ❋ Tab 10 mg - Available on a PSO ................................................ .9 INSULIN SYRINGES, disposable with attached needle Maximum of 100 dev per prescription. ❋ Syringe 0. ml with 0 g x 8 mm needle .................................. 1.9 1.9 (1.99) ❋ Syringe 0. ml with 0 g x 8 mm needle .................................. 1.9 1.9 (1.99) ❋ Syringe 1 ml with 0 g x 8 mm needle ..................................... 1.9 1.9 (1.99) CALCIUM LACTATE-GLUCONATE ❋ Tab 1 g ..................................................................................... . .9 (.1) ETHINYLOESTRADIOL WITH NORETHISTERONE ❋ Tab ethinyloestradiol µg with norethisterone 00 µg () and tab ethinyloestradiol µg with norethisterone 1 mg (9) and tab ethinyloestradiol µg with norethisterone 00 µg () and inert tab ........................................................ . (1.80) a) Available on a PSO b) Higher subsidy of $1.80 per 8 with Special Authority CYPROTERONE ACETATE - Hospital pharmacy [HP]-specialist Tab 0 mg .............................................................................. .0 100 ✓ Merbentyl

100 10 100 10 100 10

✓ B-D Ultra Fine II B-D Ultra Fine II ✓ B-D Ultra Fine II B-D Ultra Fine II ✓ B-D Ultra Fine II B-D Ultra Fine II

0 10

✓ Calcium-Sandoz 1000 Calcium-Sandoz 1000

8 Synphasic 8

✓ Pacific Cyproterone

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Delisted Items - effective 1 January 2007 (continued)

91 CEFTRIAXONE SODIUM a) Hospital pharmacy [HP] b) Subsidy by endorsement c) Available on a PSO Subsidised only if prescribed for a dialysis or cystic fibrosis patient, or the treatment of confirmed ciprofloxacinresistant gonorrhoea, or the treatment of suspected meningitis in patients who have a known allergy to penicillin and the prescription or PSO is endorsed accordingly. Inj 00 mg ................................................................................ .99 1 (.00) Rocephin Inj 1 g ....................................................................................... .0 1 (9.00) Rocephin AMOXYCILLIN Drops 1 mg per 1. ml ........................................................ . CALCIUM FOLINATE Inj 1 mg - Hospital pharmacy [HP1] - specialist – PCT ........... .0 DOXORUBICIN - PCT only – specialist Inj 0 mg ................................................................................ 9.9 EPIRUBICIN - PCT only – specialist Inj mg per ml, ml ............................................................... 9.00 Inj mg per ml, ml ........................................................... 1.0 PROMETHAZINE HYDROCHLORIDE ❋ Inj mg per ml, 1 ml - Available on a PSO ............................. 1.8 (0.) CARBACHOL - Retail pharmacy-specialist ❋ Eye drops 1.% ........................................................................ .8 HOMATROPINE HYDROBROMIDE ❋ Eye drops % ........................................................................... 8. HYPROMELOSE ❋ Eye drops 1% ........................................................................... 1.91 FAT SUPPLEMENT - Hospital Pharmacy [HP] - Special Authority Emulsion (neutral) .................................................................. 1.0 Special Authority for Subsidy – Form: SA080 0 ml OP ✓ Ospamox Paediatric Drops ✓ Leucovorin Calcium ✓ Mayne ✓ Pharmorubicin ✓ Pharmorubicin

19 1 1

1 1 1 10

1 1 1 18 19

Phenergan 1 ml OP 1 ml OP 1 ml OP ✓ Isopto Carbachol ✓ Isopto Homatropine ✓ Methopt Forte

1,000 ml OP ✓ Calogen

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Items to be Delisted

Effective 1 May 2007

9 CALCITRIOL - Retail pharmacy-specialist ❋ Cap 0. µg ............................................................................ 1. (.) ❋ Cap 0. µg .............................................................................. .9 (8.98) AMOXYCILLIN Grans for oral liq 1 mg per ml - Available on a PSO ............. 1.00 (1.08) Grans for oral liq 0 mg per ml - Available on a PSO ............. 1. (1.8) CYCLIZINE HYDROCHLORIDE - Special Authority available - Retail pharmacy Tab 0 mg ................................................................................ 1. (.0) Special Authority for Manufacturers Price - Form: SA018 100 Rocaltrol 100 Rocaltrol 100 ml Ospamox 100 ml Ospamox 10 Marzine

Effective 1 June 2007

0 CALCIUM CARBONATE ❋ Tab 1. g ................................................................................ .0 ❋ Tab 1. g .................................................................................. . 100 0 ✓ Osteo~500 ✓ Osteo~600

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Items to be Delisted - effective 1 July 2007

8 110 OESTRADIOL WITH LEVONORGESTREL – See prescribing guideline ❋ Tab mg with µg levonorgestrel (1) and mg oestradiol tab (1) ....................................................... .0

✓ Nuvelle

FENTANYL - Only on a controlled drug form - Special Authority - Retail pharmacy – No patient co-payment payable Transdermal patch . mg, µg per hour .............................. . ✓ Durogesic Transdermal patch mg, 0 µg per hour ............................... 100. ✓ Durogesic Transdermal patch . mg, µg per hour ............................ 19.18 ✓ Durogesic Transdermal patch 10 mg, 100 µg per hour ........................... 11. ✓ Durogesic Special Authority for Subsidy - Form: SA0 TRIFLUOPERAZINE HYDROCHLORIDE Tab 1 mg .................................................................................. 9.8 (10.) CARBACHOL - Retail pharmacy-specialist ❋ Eye drops % ........................................................................... .99 PHENYLEPHRINE HYDROCHLORIDE ❋ Eye drops 0.1% ...................................................................... . POLYVINYL ALCOHOL WITH POVIDONE ❋ Eye drops 1.% with povidone 0.% ......................................... . 11 Stelazine Section 9

S29

1 18 18 11

1 ml OP 1 ml OP 1 ml OP

✓ Isopto Carbachol ✓ Isopto Frin ✓ Tears Plus ✓ Nutridrink

ORAL SUPPLEMENT 1KCAL/ML - Hospital Pharmacy [HP] - Special Authority Powder (vanilla) ..................................................................... 11.0 900 g OP Special Authority for Subsidy – Form: SA08

Effective 1 August 2007

8 OILY PHENOL ❋ Inj %, ml ............................................................................. 1.1 DEXTROSE ❋ Inj 0%, 90 ml ....................................................................... 1.00 SODIUM BICARBONATE – Not in combination Inj 8.%, 10 ml ...................................................................... 111.0 SUNSCREENS, PROPRIETARY - Retail pharmacy-specialist Oint ........................................................................................... .00 (1.00) 1 ✓ Mayne ✓ Biomed

10 1 g OP

✓ Pharmalab

S29

R V Paque

CEPHRADINE - Hospital pharmacy [HP] Cap 0 mg ............................................................................ 1.0 ✓ Velosef Cap 00 mg ............................................................................ 19.8 ✓ Velosef Inj 00 mg - Subsidy by endorsement ..................................... 1.8 ✓ Velosef Only if prescribed for a dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 1 g - Subsidy by endorsement ............................................ 1.9 ✓ Velosef Only if prescribed for a dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. ❋ Three months or six months, as applicable, dispensed all-at-once

▲

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Items to be Delisted - effective 1 August 2007 (continued)

9 ETHAMBUTOL - Retail pharmacy-specialist – No patient co-payment payable ❋ Tab 00 mg ............................................................................ 19.0 100 Note – the 100 tab pack is being replaced by a tab pack DICLOFENAC SODIUM - Special Authority available - Retail pharmacy ❋ Tab long-acting mg ............................................................ . PIMOZIDE - Retail pharmacy-specialist Tab mg ................................................................................ 1. 00 0 ✓ Myambutol

10 11 18

✓ Diclax SR ✓ Orap

AMINOACID FORMULA WITHOUT PHENYLALANINE - Hospital Pharmacy [HP] - Special Authority Liquid (grapefruit) ................................................................... .0 0 ml OP ✓ Easiphen Liquid Special Authority for Subsidy – Form: SA0

Effective 1 September 2007

S29

✓ Zyprexa ✓ Zyprexa ✓ Zyprexa

CALCIUM FOLINATE Tab 1 mg - Hospital pharmacy [HP] - specialist – PCT ................................................................ 8.90 (.0)

10 Leucovorin

GLUTEN FREE BREAD MIX - Hospital Pharmacy [HP] - Special Authority Powder ..................................................................................... . 1,000 g OP (.)

Bakels Gluten Free Bread Mix

Effective 1 October 2007

81 TESTOSTERONE ENANTHATE - Retail pharmacy-specialist Inj long-acting 250 mg - prefilled syringe ................................. .00

S29

✓ Primoteston

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Items to be Delisted - effective 1 October 2007 (continued)

111 MORPHINE SULPHATE - Only on a controlled drug form – No patient co-payment payable Suppos mg .......................................................................... 1. 1 ✓ RMS Suppos 10 mg......................................................................... 19.1 1 ✓ RMS Suppos 0 mg......................................................................... 0.1 1 ✓ RMS Suppos 0 mg......................................................................... 1.9 1 ✓ RMS DIAZEPAM Inj mg per ml, ml .............................................................. 1. (.90) a) Subsidy by endorsement b) Only on a PSO PSO must be endorsed “not for anaesthetic procedures”. 10 Diazemuls

SALMETEROL - See Prescribing Guideline Aerosol inhaler, µg per dose ............................................... . 10 dose OP ✓ Serevent Note: this product has been replaced by Serevent aerosol inhaler CFC-free AMINOACID FORMULA WITHOUT VALINE, LEUCINE AND ISOLEUCINE - Hospital Pharmacy [HP] Special Authority Powder ................................................................................. 8.8 00 g OP ✓ MSUD Aid III Special Authority for Subsidy – Form: SA0

Effective 1 February 2008

Effective 1 April 2008

GLUCOSE BLOOD DIAGNOSTIC TEST METER - Subsidy by endorsement Meter ...................................................................................... 19.00 1 ✓ Accu-Chek Advantage

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✓ fully subsidised

Section H changes to Part II

Effective 1 April 2007

CANDESARTAN (ê price) Tab mg........................................Atacand Tab 8 mg........................................Atacand Tab 1 mg......................................Atacand Tab mg......................................Atacand CEFTAZIDIME Inj 1 g.............................................Mayne Inj g.............................................Mayne EMTRICITABINE Cap 00 mg ...................................Emtriva HEPARIN WITH SODIUM CHLORIDE Inf ,000 iu with 0.9% sodium chloride, 0 ml .........................Baxter Inf ,000 iu with 0.9% sodium chloride, 00 ml .........................Baxter ONDANSETRON HYDROCHLORIDE (new listing) Inj mg per ml, ml ......................Mayne Inj mg per ml, ml ......................Mayne 1. 19.0 . 8.0 9.00 18.00 0.0 0 0 0 0 1 1 0

. . 18.00 9.00

1 1

ONDANSETRON HYDROCHLORIDE (amended description) Inj 2 mg per ml, 2 ml mg per ml amp .............................Zofran .8 Inj 2 mg per ml, 4 ml 8 mg per ml amp .............................Zofran 0.9 PAROXETINE HYDROCHLORIDE Tab 0 mg......................................Loxamine .90

0 1% Jul-0 Apo-Paroxetine Aropax Luxotine

SUMATRIPTAN Tab 0 mg......................................Arrow-Sumatriptan1.00 Tab 100 mg....................................Arrow-Sumatriptan1.00 TENOFOVIR DISOPROXIL FUMARATE Tab 00 mg....................................Viread 1.00

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

Index

Pharmaceuticals and brands A Abacavir sulphate with lamivudine ...................... 19 Accu-Chek Advantage ........................................ 1 Accu-Chek Performa .......................................... 1 Aciclovir ...................................................... 19, Actos ................................................................. 1 Adrenaline.......................................................... 1 Allersoothe......................................................... 1 Alpha-Keri Lotion ............................................... Alpha Ascorbic Acid ........................................... Aminoacid formula without phenylalanine 18, , 0 Aminoacid formula without valine, leucine and isoleucine ........................................... , 1 Amoxycillin ............................................ 9, , 8 Analog LCP ........................................................ Androderm......................................................... 1 Apo-Acyclovir .................................................... 19 Apo-Ascorbic Acid ............................................. Apo-Selegiline .................................................... Aprotinin ............................................................ Arrow-Lamotrigine ............................................. 18 Arrow-Lisinopril ................................................. 1 Arrow-Roxithromycin ......................................... 1 Arrow-Sumatriptan ....................................... 1, Ascorbic acid ..................................................... Atacand ....................................................... , Atropine sulphate ............................................... Atropt ................................................................ Avonex .............................................................. B B-D Ultra Fine II .................................................. Bakels Gluten Free Bread Mix ............................. 0 Bakels Gluten Free Health Bread Mix ................... 1 Benhex .............................................................. 9 Betadine Skin Prep ............................................. Betaferon ..................................................... , 0 Betamethasone dipropionate .............................. 0 Betamethasone valerate with fusidic acid ............ Bisacodyl ........................................................... BK Lotion ........................................................... Bonjela .............................................................. Brimonidine tartrate ............................................ 1 C Calamine...................................................... , Calcitriol ...................................................... 8, 8 Calcium-Sandoz 1000 ........................................ Calcium carbonate ....................................... 18, 8 Calcium folinate ........................................... , 0 Calcium lactate-gluconate .................................. Calogen ............................................................. Candesartan................................................. , Carbachol .................................................... , 9 Carboplatin ........................................................ 19 Carboplatin Ebewe ............................................. 19 Carbosorb-X ................................................ , 1 Carvedilol ........................................................... Cefamandole nafate ........................................... Ceftazidime ........................................................ Ceftriaxone sodium ...................................... , 0 Celapram ........................................................... 18 Cephalexin monohydrate .................................... Cephradine ........................................................ 9 Cetomacrogol .................................................... 8 Charcoal ...................................................... , 1 Chloroform ........................................................ 0 Choline salicylate with cetalkonium chloride........ Cisplatin........................................... 19, 8, 9, 1 Cisplatin Ebewe............................................ 19, 8 Citalopram hydrobromide ................................... 18 Climara 100 ....................................................... 1 Climara 0 ......................................................... 1 Clopine .............................................................. 18 Clozapine ........................................................... 18 Coal tar .............................................................. 9 Codalax ............................................................. Codalax Forte ..................................................... Colistin-Link ....................................................... Colistin sulphomethate ....................................... Collodion flexible ................................................ 0 Colymycin-M ..................................................... Condyline........................................................... 1 Copaxone .......................................................... Cyclizine hydrochloride .................... , 9, 1, 8 Cyclophosphamide ............................................ Cyproterone acetate ........................................... Cytarabine ................................................... , 0 D D-Penamine ....................................................... 9 Danthron with poloxamer.................................... Dexamphetamine sulphate.................................. 9 Dextrose .................................... 1, 18, 0, , 9 Diazemuls .......................................................... 1 Diazepam........................................................... 1 Diclax SR ............................................... 1, , 0 Diclofenac sodium ........................... 1, 1, , 0 Dicyclomine hydrochloride ................................. Diflucan ............................................................. Dilatrend ............................................................ Dipivefrin hydrochloride ...................................... Diprosone .......................................................... 0 Diprosone OV..................................................... 0 Dopress ............................................................. 9 Dothiepin hydrochloride...................................... 9 Doxorubicin .......................................................

Index

Pharmaceuticals and brands DP Lotion ........................................................... DP Lotn HC ........................................................ Durogesic .................................................... 19, 9 Dyzole ............................................................... E Easiphen Liquid............................................ 18, 0 Emtricitabine ................................................ 1, Emtriva ........................................................ 1, Endoxan............................................................. Epirubicin........................................................... Ethambutol ........................................................ 0 Ethambutol hydrochloride ................................... 18 Ethinyloestradiol with norethisterone ................... Etoposide........................................................... 0 F Fat supplement ............................................ , Fentanyl ....................................................... 19, 9 Ferro-F-Tabs ...................................................... 18 Ferrous fumarate with folic acid .......................... 18 Flagyl - S ........................................................... 9 Fluconazole ........................................................ Fluorouracil Ebewe ............................................. 19 Fluorouracil sodium............................................ 19 Fluphenazine decanoate ..................................... Foremount Child’s Silicone Mask ........................ Fortisip Powder .................................................. 0 Fucicort ............................................................. Fucidin ............................................................... 8 Fucithalmic ........................................................ Fusidic acid.................................................. , 8 G Gamma benzene hexachloride ............................ 9 Gastrogel ........................................................... Gastrosoothe ..................................................... 1 Glatiramer acetate .............................................. Glucose blood diagnostic test meter ....... 1, 1, 1 Glucose dehydrogenase ............................... 1, 1 Gluten free bread mix ................................... 1, 0 Glycerol ....................................................... , 0 Glycerol with paraffin and cetyl alcohol ............... Granocol ............................................................ 0 H Heparin sodium.................................................. Heparin with sodium chloride ............................. Homatropine hydrobromide ................................ Humulin 0/0 ................................................... Humulin N .......................................................... Hydrocortisone with wool fat and mineral oil ....... Hydroderm Lotion .............................................. Hydrogen peroxide ............................................. 8 Hydroxocobalamin ............................................. 1 Hyoscine n-butylbromide ................................... 1 Hypromelose ..................................................... I Imigran .............................................................. Insulin aspart ..................................................... 0 Insulin isophane ................................................. Insulin isophane with insulin neutral.................... Insulin syringes .................................................. Interferon alpha-a ............................................. Interferon beta-1-alpha ....................................... Interferon beta-1-beta................................... , 0 Isoniazid ............................................................ 9 Isopto Carbachol .......................................... , 9 Isopto Frin.......................................................... 9 Isopto Homatropine ............................................ K Keflex ................................................................ Kivexa ................................................................ 19 L Lamotrigine........................................................ 18 Lansoprazole ..................................................... 1 Leucovorin ......................................................... 0 Leucovorin Calcium ........................................... Lipex.................................................................. 8 Liquigen ............................................................. Lisinopril ............................................................ 1 Loxamine ..................................................... 1, M Mandol .............................................................. Marzine............................................ , 9, 1, 8 Maxamaid MSUD ............................................... Maxamaid XP ..................................................... Maxamum MSUD ............................................... Maxamum XP .................................................... Menthol ............................................................. 8 Merbentyl........................................................... Methopt Forte..................................................... Methylphenidate hydrochloride ..................... 1, Metronidazole .................................................... 9 Mogine .............................................................. 18 Morphine sulphate........................................ 1, 1 MSUD Aid .......................................................... MSUD Aid III ................................................ , 1 MSUD Maxamaid ............................................... MSUD Maxamum ............................................... Mucilaginous laxatives ....................................... Mucilaginous laxatives with stimulants ............... 0 Mucilax .............................................................. Multiparin........................................................... Myambutol................................................... 18, 0 N Naloxone hydrochloride ...................................... 0 Naproxen ...........................................................

Index

Pharmaceuticals and brands Naxen ................................................................ Niacin-Odan ....................................................... Nicotinic acid ..................................................... Nilstat ................................................................ NovoRapid ......................................................... 0 NovoRapid Penfill ............................................... 0 Nutridrink ........................................................... 9 Nuvelle......................................................... 19, 9 Nystatin ............................................................. O Oestradiol .......................................................... 1 Oestradiol with levonorgestrel ....................... 19, 9 Oily phenol ......................................................... 9 Olanzapine ................................................... 1, 0 Ondansetron hydrochloride................................. Optium............................................................... 1 Optium Xceed .................................................... 1 Oral supplement 1kcal/ml ............................. 0, 9 Orap .................................................................. 0 Orap Forte .......................................................... 18 Ospamox ..................................................... 9, 8 Ospamox Paediatric Drops ................................. Osteo~00 ................................................. 18, 8 Osteo~00 ................................................. 18, 8 Oxytocin ...................................................... 8, 1 P Pacific Cyproterone ............................................ Paroxetine hydrochloride .............................. 1, Penicillamine...................................................... 9 Pharmorubicin ................................................... Phenergan ......................................................... Phenylephrine hydrochloride .............................. 9 Pimozide ...................................................... 18, 0 Pinetarsol........................................................... Pioglitazone ....................................................... 1 Podophylotoxin .................................................. 1 Polysiloxane....................................................... Polyvinyl alcohol ................................................ 0 Polyvinyl alcohol with povidone .......................... 9 Povidone iodine ................................................. Primoteston ....................................................... 0 Promethazine hydrochloride ......................... 1, Propine .............................................................. Propylene glycol ................................................ 0 Q QV ..................................................................... R Requip Follow-on Pack....................................... 1 Requip Starter Pack............................................ 1 Ridal .................................................................. 18 Risperidone........................................................ 18 Ritalin SR ..................................................... 1, Rocaltrol ...................................................... 8, 8 Rocephin ........................................................... Rocephin IV ....................................................... 0 Roferon-A .......................................................... Ropinirole hydrochloride..................................... 1 Roxithromycin.................................................... 1 R V Paque .......................................................... 9 Rynacrom Forte ........................................... 8, 8 S Salicylic acid ...................................................... 9 Salmeterol ................................................... 19, 1 Selegiline hydrochloride ..................................... Serevent ...................................................... 19, 1 Simvastatin .................................................. 8, Sodium bicarbonate ............................... 19, , 9 Sodium cromoglycate ............................ 19, 8, 8 Sodium fluoride .................................................. 8 Solox ................................................................. 1 Space Chamber ................................................. Spacer devices and masks ................................. Stelazine ...................................................... , Stelazine Section 9 ..................................... 9, 0 Sumatriptan ........................................... 1, , Sunscreens, proprietary ..................................... 9 Synphasic 8 ..................................................... Syntocinon................................................... 8, 1 Syntometrine...................................................... 8 T Tar with triethanolamine lauryl sulphate and fluo rescein .............................................. Tears Plus.......................................................... 9 Tenofovir disoproxil fumarate ....................... 1, Testosterone ...................................................... 1 Testosterone enanthate ...................................... 0 Thymol glycerin ................................................. 8 Tinidazole .......................................................... Trasylol.............................................................. Trifluoperazine hydrochloride ............ , , 9, 0 V Valaciclovir hydrochloride................................... Valtrex ............................................................... Velosef .............................................................. 9 Viread .......................................................... 1, Vistil .................................................................. 0 Vistil Forte .......................................................... 0 Voltaren D .......................................................... 1 Voltaren SR .................................................. 1, W Water ..................................................... 19, , 8 Wool fat with mineral oil ..................................... X XP Analog LCP ...................................................

Index

Pharmaceuticals and brands XP Maxamaid ..................................................... XP Maxamum .................................................... Z Zocor ................................................................. Zofran ................................................................ Zovirax ............................................................... Zyprexa ........................................................ 1, 0

Metadata

Title

Schedule Update - effective 1 Apr 2007

Abstract

New Zealand Pharmaceutical Schedule Effective 1 April 2007 Cumulative for January, February, March and April 2007 Section H for April 2007 Contents Two new medicines funded for people with HIV infection …. 4 Pioglitazone – widened access …. 4 New…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.